They’re in reality buying a fairly distressed asset and some distro deals is my guess
Paul Long Little Green Pharma announced this on Linked in 14 January 2026
Today we announced a proposed merger between Little Green Pharma and Cannatrek, a significant milestone for both businesses and the global medicinal cannabis industry.
Bringing together two pioneering, highly complementary platforms, this combination reflects the growing importance of scale, strong brands, operational capability and, most importantly, great people. More to come.
Long’s LI profile says
Paul Long is an accomplished leader with a proven track record in the health and pharmaceutical industries. As the former Chief Executive Officer of Onsite Health Solutions, he led the company to become a market leader before its successful acquisition by Sanitarium in 2012. Since then, Paul worked as a consultant in enterprise health, health technology, and retail pharmaceutical sectors.
In 2018, Paul joined Little Green Pharma as Chief Operations Officer and in August 2023 was appointed the Chief Executive Officer. He has played a pivotal role in building the company and achieving strong revenue growth, increasing from AUD 2.2 million in 2020 to AUD 19.9 million in 2023. He also led the company’s expansion into international markets, securing a pipeline of over AUD 30 million in Europe.
With extensive expertise in the global medicinal cannabis sector and the capital markets, Paul is a forward-thinking leader who continues to drive success and innovation in the industry.
